Gepefrine: Difference between revisions

Jump to navigation Jump to search
m (Protected "Gepefrine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Drugbox
{{Drugbox
| IUPAC_name       = 3-(2-aminopropyl)phenol
| Watchedfields = changed
| image             = gepefrine.png
| verifiedrevid = 447926897
| CAS_number        =  
| IUPAC_name = (±)-3-(2-aminopropyl)phenol
| ATC_prefix        = C01
| image =Gepefrine.png
| ATC_suffix        = CA15
| imagename = Gepefrine
| PubChem          = 102551
 
| DrugBank          =  
<!--Clinical data-->
| C=9|H=13|N=1|O=1
| tradename =
| molecular_weight  = 151.206 g/mol
| pregnancy_category =
| bioavailability   =
| legal_status = Rx-only
| protein_bound    =  
| routes_of_administration =
| metabolism       =  
 
| elimination_half-life =  
<!--Pharmacokinetic data-->
| excretion         =  
| bioavailability =
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
| metabolism =
| pregnancy_US      = <!-- A / B            / C / D / X -->
| elimination_half-life =
| pregnancy_category=
| excretion =
| legal_AU          = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
 
| legal_CA          = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
<!--Identifiers-->
| legal_UK          = <!-- GSL        / P      / POM / CD / Class A, B, C -->
| CAS_number_Ref = {{cascite|correct|??}}
| legal_US          =  <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| CAS_number = 1075-61-2
| legal_status      =  
| CAS_supplemental = <br />18840-47-6 ((''S'')-form)<br />60763-48-6 ([[tartrate]])
| routes_of_administration =  
| ATC_prefix = C01
| ATC_suffix = CA15
| PubChem = 219105
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 189921
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = V51RRX51VH
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07150
 
<!--Chemical data-->
| C = 9 | H = 13 | N = 1 | O = 1
| molecular_weight = 151.206 g/mol
| smiles = OC1=CC(C[C@H](C)N)=CC=C1
| InChI = 1/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3/t7-/m0/s1
| InChIKey = WTDGMHYYGNJEKQ-ZETCQYMHBW
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3/t7-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WTDGMHYYGNJEKQ-ZETCQYMHSA-N
}}
}}
__NOTOC__
__Notoc__
{{SI}}
{{CMG}}
{{CMG}}
==Overview==


{{Editor Join}}
'''Gepefrine''' ([[International Nonproprietary Name|INN]]; trade names '''Pressionorm''' and '''Wintonin'''), also known as '''3-hydroxyamphetamine''', '''''meta''-hydroxyamphetamine''',<ref name="pmid918344">{{cite journal | author = Jonsson J | title = Identification of metahydroxyamphetamine as a metabolite of amphetamine in the rat | journal = Research Communications in Chemical Pathology and Pharmacology | volume = 18 | issue = 2 | pages = 189–99 |date=October 1977 | pmid = 918344 | doi = | url = }}</ref> and '''α-methyl-''meta''-tyramine''', is an [[antihypotensive]] or [[sympathomimetic]] agent of the [[amphetamine]] family that is marketed in certain [[Europe]]an countries.<ref name="Index Nominum 2000: International Drug Directory">{{cite book | title = Index Nominum 2000: International Drug Directory | url = http://books.google.com/books?id=5GpcTQD_L2oC&pg=PA487 | accessdate = 24 April 2012 | year = 2000 | publisher = Taylor & Francis US | isbn = 978-3-88763-075-1 | page = 487}}</ref><ref name="Macdonald1997">{{cite book | author = F.. Macdonald | title = Dictionary of Pharmacological Agents | url = http://books.google.com/books?id=DeX7jgInYFMC&pg=PA127 | accessdate = 24 April 2012 | year = 1997 | publisher = CRC Press | isbn = 978-0-412-46630-4 | page = 127}}</ref>


It is a known [[metabolite]] of [[amphetamine]] in rats.<ref name="pmid918344" />


==[[Gepefrine (patient information)|For patient information, click here]]==
== See also ==
* [[Norfenfluramine]]
* [[Metaraminol]]


==Overview==
 
'''Gepefrine''' is a cardiac stimulant.
== References ==
{{Reflist|2}}




{{Cardiac stimulants excluding cardiac glycosides}}
{{Phenethylamines}}


[[Category:Phenols]]
[[Category:Phenols]]
[[Category:Phenethylamines]]
[[Category:Sympathomimetics]]
[[Category:Drugs]]
[[Category:Drug]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 15:13, 13 April 2015

Gepefrine
Clinical data
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC9H13NO
Molar mass151.206 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Gepefrine

Articles

Most recent articles on Gepefrine

Most cited articles on Gepefrine

Review articles on Gepefrine

Articles on Gepefrine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Gepefrine

Images of Gepefrine

Photos of Gepefrine

Podcasts & MP3s on Gepefrine

Videos on Gepefrine

Evidence Based Medicine

Cochrane Collaboration on Gepefrine

Bandolier on Gepefrine

TRIP on Gepefrine

Clinical Trials

Ongoing Trials on Gepefrine at Clinical Trials.gov

Trial results on Gepefrine

Clinical Trials on Gepefrine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Gepefrine

NICE Guidance on Gepefrine

NHS PRODIGY Guidance

FDA on Gepefrine

CDC on Gepefrine

Books

Books on Gepefrine

News

Gepefrine in the news

Be alerted to news on Gepefrine

News trends on Gepefrine

Commentary

Blogs on Gepefrine

Definitions

Definitions of Gepefrine

Patient Resources / Community

Patient resources on Gepefrine

Discussion groups on Gepefrine

Patient Handouts on Gepefrine

Directions to Hospitals Treating Gepefrine

Risk calculators and risk factors for Gepefrine

Healthcare Provider Resources

Symptoms of Gepefrine

Causes & Risk Factors for Gepefrine

Diagnostic studies for Gepefrine

Treatment of Gepefrine

Continuing Medical Education (CME)

CME Programs on Gepefrine

International

Gepefrine en Espanol

Gepefrine en Francais

Business

Gepefrine in the Marketplace

Patents on Gepefrine

Experimental / Informatics

List of terms related to Gepefrine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Gepefrine (INN; trade names Pressionorm and Wintonin), also known as 3-hydroxyamphetamine, meta-hydroxyamphetamine,[1] and α-methyl-meta-tyramine, is an antihypotensive or sympathomimetic agent of the amphetamine family that is marketed in certain European countries.[2][3]

It is a known metabolite of amphetamine in rats.[1]

See also


References

  1. 1.0 1.1 Jonsson J (October 1977). "Identification of metahydroxyamphetamine as a metabolite of amphetamine in the rat". Research Communications in Chemical Pathology and Pharmacology. 18 (2): 189–99. PMID 918344.
  2. Index Nominum 2000: International Drug Directory. Taylor & Francis US. 2000. p. 487. ISBN 978-3-88763-075-1. Retrieved 24 April 2012.
  3. F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 127. ISBN 978-0-412-46630-4. Retrieved 24 April 2012.


Template:Phenethylamines